Atossa Therapeutics
ATOS
#9237
Rank
NZ$0.17 B
Marketcap
NZ$1.38
Share price
5.24%
Change (1 day)
-32.18%
Change (1 year)

Atossa Therapeutics (ATOS) Fails to deliver data

Key failure to deliver metrics for Atossa Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Atossa Therapeutics (ATOS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Atossa Therapeutics (ATOS) - since 2018

Volume in USD (price x number of shares), data since 2018

Atossa Therapeutics (ATOS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025NZ$0.56 M-69.52%
2024NZ$1.86 M265.91%
2023NZ$0.5 M-93.57%
2022NZ$7.92 M-92.88%
2021NZ$0.11 B731.9%
2020NZ$13.37 M-10.09%
2019NZ$14.87 M138.47%
2018NZ$6.23 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
NZ$54.31 MNZ$94.31 M๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$14.74 MNZ$33.36 M๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$22.12 MNZ$37.65 M๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ$0 MNZ$0.33 M๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
NZ$0.05 MNZ$13.8 M๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ$0.77 MNZ$3.68 M๐Ÿ‡บ๐Ÿ‡ธ USA